BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25774696)

  • 1. Mesenchymal stromal cell secretome up-regulates 47 kDa CXCR4 expression, and induce invasiveness in neuroblastoma cell lines.
    Shankar V; Hori H; Kihira K; Lei Q; Toyoda H; Iwamoto S; Komada Y
    PLoS One; 2015; 10(3):e0120069. PubMed ID: 25774696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cells may enhance metastasis of neuroblastoma via SDF-1/CXCR4 and SDF-1/CXCR7 signaling.
    Ma M; Ye JY; Deng R; Dee CM; Chan GC
    Cancer Lett; 2011 Dec; 312(1):1-10. PubMed ID: 21906874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the nuclear factor-κB signaling pathway in the regulation of CXC chemokine receptor-4 expression in neuroblastoma cells induced by tumor necrosis factor-α.
    Zhi Y; Lu H; Duan Y; Sun W; Guan G; Dong Q; Yang C
    Int J Mol Med; 2015 Feb; 35(2):349-57. PubMed ID: 25503960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB signaling pathway confers neuroblastoma cells migration and invasion ability via the regulation of CXCR4.
    Zhi Y; Duan Y; Zhou X; Yin X; Guan G; Zhang H; Dong Q; Yang K
    Med Sci Monit; 2014 Dec; 20():2746-52. PubMed ID: 25527973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal cell-derived factor-1α and macrophage migration-inhibitory factor induce metastatic behavior in CXCR4-expressing colon cancer cells.
    Shin HN; Moon HH; Ku JL
    Int J Mol Med; 2012 Dec; 30(6):1537-43. PubMed ID: 23023114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases.
    Russell HV; Hicks J; Okcu MF; Nuchtern JG
    J Pediatr Surg; 2004 Oct; 39(10):1506-11. PubMed ID: 15486895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL12 does not attract CXCR4+ human metastatic neuroblastoma cells: clinical implications.
    Airoldi I; Raffaghello L; Piovan E; Cocco C; Carlini B; Amadori A; Corrias MV; Pistoia V
    Clin Cancer Res; 2006 Jan; 12(1):77-82. PubMed ID: 16397027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma.
    Zhang L; Yeger H; Das B; Irwin MS; Baruchel S
    Neoplasia; 2007 Jan; 9(1):36-46. PubMed ID: 17325742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditioned medium from mesenchymal stem cells enhances the migration of hepatoma cells through CXCR4 up-regulation and F-actin remodeling.
    Li X; Luo Q; Sun J; Song G
    Biotechnol Lett; 2015 Mar; 37(3):511-21. PubMed ID: 25351811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis.
    Tang CH; Tan TW; Fu WM; Yang RS
    Carcinogenesis; 2008 Jan; 29(1):35-43. PubMed ID: 17916907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PGK1 as predictor of CXCR4 expression, bone marrow metastases and survival in neuroblastoma.
    Ameis HM; Drenckhan A; von Loga K; Escherich G; Wenke K; Izbicki JR; Reinshagen K; Gros SJ
    PLoS One; 2013; 8(12):e83701. PubMed ID: 24376734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic fragments of fibronectin function as matrikines driving the chemotactic affinity of prostate cancer cells to human bone marrow mesenchymal stromal cells via the α5β1 integrin.
    Joshi R; Goihberg E; Ren W; Pilichowska M; Mathew P
    Cell Adh Migr; 2017 Jul; 11(4):305-315. PubMed ID: 27715399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4 expression heterogeneity in neuroblastoma cells due to ligand-independent regulation.
    Carlisle AJ; Lyttle CA; Carlisle RY; Maris JM
    Mol Cancer; 2009 Dec; 8():126. PubMed ID: 20028517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion.
    Fontanella R; Pelagalli A; Nardelli A; D'Alterio C; Ieranò C; Cerchia L; Lucarelli E; Scala S; Zannetti A
    Cancer Lett; 2016 Jan; 370(1):100-7. PubMed ID: 26517945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-β1 in the microenvironment of ischemia reperfusion-injured kidney enhances the chemotaxis of mesenchymal stem cells to stromal cell-derived factor-1 through upregulation of surface chemokine (C-X-C motif) receptor 4.
    Si XY; Li JJ; Yao T; Wu XY
    Mol Med Rep; 2014 May; 9(5):1794-8. PubMed ID: 24573381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-1-mediated mesenchymal stem cell tumor tropism is dependent on crosstalk with stromal derived growth factor 1/C-X-C chemokine receptor 4 axis.
    Ho IA; Yulyana Y; Sia KC; Newman JP; Guo CM; Hui KM; Lam PY
    FASEB J; 2014 Oct; 28(10):4359-68. PubMed ID: 25271298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
    Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
    FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma.
    Chang HH; Chen CH; Chou CH; Liao YF; Huang MJ; Chen YH; Wang WJ; Huang J; Hung JS; Ho WL; Jeng YM; Che MI; Lee H; Lu MY; Yang YL; Jou ST; Lin DT; Lin KH; Hsu WM; Huang MC
    Clin Cancer Res; 2013 Apr; 19(7):1705-16. PubMed ID: 23444218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway.
    Yu T; Wu Y; Helman JI; Wen Y; Wang C; Li L
    Mol Cancer Res; 2011 Feb; 9(2):161-72. PubMed ID: 21205837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion.
    Meier R; Mühlethaler-Mottet A; Flahaut M; Coulon A; Fusco C; Louache F; Auderset K; Bourloud KB; Daudigeos E; Ruegg C; Vassal G; Gross N; Joseph JM
    PLoS One; 2007 Oct; 2(10):e1016. PubMed ID: 17925864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.